Steward Partners Investment Solutions’s Ginkgo Bioworks DNA Stock Holding History

Steward Partners Investment Solutions’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$58K	Buy	+1,250	New	+$64.7K	0.01%	254

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steward Partners Investment Solutions's DNA Position: Q1 2024 in Review

Steward Partners Investment Solutions opened a new position in Ginkgo Bioworks (DNA) in Q1 2024: 1,250 shares worth $58K. The stake represents 0.01% of the portfolio and ranks #254 among its holdings.

342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

Steward Partners Investment Solutions held 1,250 shares of Ginkgo Bioworks worth $58K as of Q1 2024.
Ginkgo Bioworks was a new Steward Partners Investment Solutions position in Q1 2024.
Ginkgo Bioworks made up 0.01% of Steward Partners Investment Solutions's portfolio in Q1 2024, its #254 holding.
342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Steward Partners Investment Solutions's 13F filing for Q1 2024, filed 15 May 2024.